Dapagliflozin and kidney outcomes in patients with heart failure with mildly reduced or preserved ejection fraction: a prespecified analysis of the DELIVER randomized …

FR Mc Causland, BL Claggett, M Vaduganathan… - JAMA …, 2023 - jamanetwork.com
Importance Sodium-glucose cotransporter 2 inhibitors are known to reduce heart failure
events and slow progression of kidney disease among patients with heart failure and a …
被引用次数：55 相关文章

Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER …

FR Mc Causland, BL Claggett, M Vaduganathan… - 2023 - pubmed.ncbi.nlm.nih.gov
Importance Sodium-glucose cotransporter 2 inhibitors are known to reduce heart failure
events and slow progression of kidney disease among patients with heart failure and a …
[HTML] nih.gov

[HTML][HTML] Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the …

FR Mc Causland, BL Claggett, M Vaduganathan… - JAMA …, 2023 - ncbi.nlm.nih.gov
Objective To determine the effect of dapagliflozin on cardiovascular and kidney outcomes
and the influence of baseline kidney disease among patients with heart failure and a mildly …

Dapagliflozin and kidney outcomes in patients with heart failure with mildly reduced or preserved ejection fraction

FR Mc Causland, BL Claggett, M Vaduganathan… - JAMA …, 2022 - eprints.gla.ac.uk
Importance: Sodium-glucose cotransporter 2 inhibitors are known to reduce heart failure
events and slow progression of kidney disease among patients with heart failure and a …

Dapagliflozin and Kidney Outcomes in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER …

FR Mc Causland, BL Claggett… - JAMA …, 2023 - scholars.northwestern.edu
Importance: Sodium-glucose cotransporter 2 inhibitors are known to reduce heart failure
events and slow progression of kidney disease among patients with heart failure and a …

Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER …

FR Mc Causland, BL Claggett, M Vaduganathan… - JAMA …, 2023 - europepmc.org
Objective To determine the effect of dapagliflozin on cardiovascular and kidney outcomes
and the influence of baseline kidney disease among patients with heart failure and a mildly …

Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER …

FR Mc Causland, BL Claggett, M Vaduganathan… - JAMA …, 2023 - europepmc.org
Objective To determine the effect of dapagliflozin on cardiovascular and kidney outcomes
and the influence of baseline kidney disease among patients with heart failure and a mildly …